Back to 
Candriam S.C.A.
Candriam S.C.A.
RAREShowing 8 of 28 quarters
Position history for Candriam S.C.A.'s holdings in ULTRAGENYX PHARMACEUTICAL IN
Candriam S.C.A. holds 1.1M shares of RARE (ULTRAGENYX PHARMACEUTICAL IN), worth $23M as of 2026-Q1. The position was increased (+37.1% shares). RARE represents 0.1% of Candriam S.C.A.'s portfolio.
Current Value
$23M
Current Shares
1.1M
Total Value Change
-$5.3M
Total Shares Change
+407,240
Quarter-by-Quarter History
Other major holders of RARE: Capital Research Global Investors, Capital International Investors, FEDERATED HERMES, INC.